ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.774,71
0,43%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08784
0,15%
Bitcoin
67.888,75
-2,17%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Astria Therapeutics Inc (ATXS)

  7. Astria Therapeutics Inc (ATXS) News

ATXS

Astria Therapeutics (ATXS)

Astria Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ATXS
DatumZeitQuelleÜberschriftSymbolFirma
24/05/202414h00Business WireAstria Therapeutics to Present at Upcoming Eastern Allergy ConferenceNASDAQ:ATXSAstria Therapeutics Inc
23/05/202414h00Business WireAstria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology CongressNASDAQ:ATXSAstria Therapeutics Inc
09/05/202422h10Business WireAstria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate UpdateNASDAQ:ATXSAstria Therapeutics Inc
09/05/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATXSAstria Therapeutics Inc
08/05/202414h00Business WireAstria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual MeetingNASDAQ:ATXSAstria Therapeutics Inc
02/05/202422h00Business WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
09/04/202414h00Business WireAstria Therapeutics Appoints Sunil Agarwal to Its Board of DirectorsNASDAQ:ATXSAstria Therapeutics Inc
03/04/202422h10Business WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
25/03/202412h30Business WireAstria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAENASDAQ:ATXSAstria Therapeutics Inc
05/03/202422h10Business WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
04/03/202423h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATXSAstria Therapeutics Inc
04/03/202423h20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ATXSAstria Therapeutics Inc
04/03/202422h10Business WireAstria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate UpdateNASDAQ:ATXSAstria Therapeutics Inc
04/03/202422h02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ATXSAstria Therapeutics Inc
20/02/202414h00Business WireAstria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual MeetingNASDAQ:ATXSAstria Therapeutics Inc
14/02/202421h48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
14/02/202421h00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
14/02/202414h36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
12/02/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
12/02/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
12/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
12/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
12/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
12/02/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
06/02/202414h00Business WireAstria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:ATXSAstria Therapeutics Inc
05/02/202422h00Business WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
31/01/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATXSAstria Therapeutics Inc
31/01/202414h59Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ATXSAstria Therapeutics Inc
30/01/202423h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
30/01/202415h08Business WireAstria Therapeutics Announces Pricing of $125 Million Underwritten OfferingNASDAQ:ATXSAstria Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ATXS

Kürzlich von Ihnen besucht

ASX
SYISSB
USOTC
MAWAF
Maruwa (PK)
USOTC
NTTCF
Netcents Technology (CE)
NASDAQ
LATG
Chenghe Acquisition I
AMEX
MTNB
Matinas Biopharma
USOTC
CTOSW
Custom Truck One Source (PK)
USOTC
CTIHY
China Insurance (PK)
COIN
ACREEUR
EU
5152T
5152T
BIT
S28976
Societe Generale Effekten
EU
FRSG00014OJ3
SG Issuer Sg Issuer Mc F...
EU
FR001400N335
SG Issuer Sg Issuer Mc M...
NASDAQ
FRWAW
PWP Forward Acquisition ...
BIT
F17371
Vontobel Financial Produ...
EU
ALECR
Eurofins Cerep
USOTC
MMXXF
MMX Mineracao E Metalicos (GM)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten